The present invention relates to novel compounds of formula (I): <;CHEM>; Which act as 5HT2C receptor modulators. These compounds are useful in pharmaceutical compositions whose use includes the treatment of obesity. <;IMAGE>; <;IMAGE>; <;IMAGE>; <;IMAGE>; <;IMAGE>; <;IMAGE>; <;IMAGE>;